Introduction
Activation of T cells through the TCR is followed by a cascade and favours the growth of cells which produce IL-4 and IL-5, while inhibiting the production of IFN-γ (9). of intracellular signalling events, culminating in the transition from the G 0 to the G 1 phase of the cell cycle and the induction IL-5 is a cytokine expressed by T cells, which in humans selectively stimulates differentiation, proliferation and funcof cytokine gene expression, leading to secretion of IL-2 and surface expression of the IL-2 receptor (IL-2R). The interaction tional activation of the eosinophil lineage, and plays a major role in the induction of eosinophilia associated with helminth of IL-2 with the IL-2R initiates a second phosphorylation cascade and sequential wave of gene expression that drives the infection and allergic disease (10) (11) (12) (13) . In vitro stimulation of human peripheral blood mononuclear cells (PBMC) with agents cells to S phase, followed by clonal expansion (1,2). In addition to activating T cell proliferative response genes, IL-2 can also which mimic TCR signalling induces IL-5 mRNA expression, which is inhibited by dexamethasone, cyclosporin A (CsA) induce expression of the cytokines IL-3, granulocyte macrophage colony stimulating factor (GM-CSF) (3), IFN-γ (4), tumor and FK506 (14) (15) (16) . A correlation between elevated eosinophil production, and IL-5 mRNA and protein levels has also been necrosis factor (TNF)-α, TNF-β (5), IL-4 (6) and IL-5 (7) . The mechanism by which IL-2 stimulates cytokine transcription has observed in PBMC and sera of patients receiving IL-2 immunotherapy (17, 18) . In vitro rIL-2 treatment of PBMC isolated from not been clearly defined. Primed lymphocytes also express receptors for IL-4, which share a common γ chain with the ILindividuals with eosinophilia also elicited IL-5 mRNA expression (7, 19) . Dexamethasone inhibits IL-5 expression induced 2R (8) . IL-4 has a role in T cell proliferation and differentiation, by IL-2 (14) , but there is little other information about the mechgradient centrifugation, washed twice in PBS and resuspended at 1ϫ10 6 cells/ml in complete medium comprising anism of IL-2-mediated IL-5 gene activation.
The immunosuppressive agent CsA inhibits T cell prolifera-RPMI 1640 supplemented with 10% (v/v) heat-inactivated FCS (PA Biologicals), 2 mM L-glutamine, 10 mM HEPES tion following TCR activation by interfering with calciumdependent signalling events, thereby preventing cytokine (pH 7.3) and 200 U/ml penicillin/200 µg/ml streptomycin (Commonwealth Serum Laboratories, Victoria, Australia). Cells gene transcription (20). The antiproliferative effect can be circumvented by addition of exogenous IL-2 or IL- 4 (20) .
were incubated at 37°C in a humidified 5% CO 2 atmosphere. Activated T lymphocytes were prepared by stimulating human Rapamycin (RAP) causes T cell growth arrest in the G 1 phase of the cell cycle by blocking the proliferative signals delivered PBMC with PHA (1 µg/ml) on day 0 and maintaining cells in culture for a 7 day period with addition of rIL-2 (5 U/ml) on by growth promoting lymphokines. In contrast to CsA, addition of IL-2 or IL-4 fails to overcome growth inhibition by RAP day 3. (21, 22) . The effect of RAP on cytokine expression is controverCell surface phenotyping and proliferation assay sial. Some reports describe an inhibitory effect of RAP on TCR-induced T cell cytokine expression, whereas others Cell surface phenotype was analysed on an Epics XL flow cytometer (Coulter, Hialeah, FL). Cells were stained with do not (21, 23, 24) . Asthma is a condition with prominent eosinophilic infiltration into the affected tissue. There is considLeu-4-FITC (anti CD3) and anti-IL-2R (CD25)-phycoerythrin (Becton Dickinson, Mountain View, CA) on ice for 30 min, erable evidence that IL-5 is prominent in clinical asthma (11) and in a mouse model of asthma, eosinophilic infiltration was washed twice with PBS, and resuspended in PBS supplemented with 1% FCS. Proliferation assays were performed abolished in animals with homozygous disruption of the IL-5 genes (25) . CsA has been shown to be effective in the with 200 µl aliquots of 1ϫ10 6 cells/ml in 96-well flat-bottom tissue culture plates. Duplicate wells were treated with various treatment of severe asthma. In a carefully controlled trial in glucocorticoid-dependent asthmatics, addition of CsA concentrations of RAP for 30 min before addition of either 1 µg/ml PHA, 10 U/ml rIL-2 or medium alone. Cells were enabled a reduction in glucocorticoid dose (26) . RAP has been proposed as a therapeutic agent for the treatment of cultured for 48 h and pulsed with 0.5 µCi [ 3 H]thymidine (Amersham) per well 4 h prior to harvesting with a plate this condition (27) .
In light of the in vivo significance of IL-2 induction of IL-5-harvester (Innovonics, Melbourne, Australia). Incorporated radioactivity was measured by liquid scintillation (Packard, mediated eosinophilia, we compared the regulation of human IL-5 expression induced by IL-2 and by phytohaemagglutinin Groningen, The Netherlands). (PHA), which, while it binds many cell surface molecules, RNA extraction and cDNA synthesis has been well described to activate signalling pathways associated with the TCR (28, 29) . Both stimuli induced similar Samples of 1ϫ10 6 cells were lysed in 100 µl of 4 M guanidium isothiocyanate, 25 mM sodium citrate, pH 7, 0.5% sarcosyl kinetics of IL-5 mRNA expression, which was dependent on de novo protein synthesis. However, differential regulation of and 0.1 M 2-mercaptoethanol. Then, 20 µg tRNA was added and total cellular RNA extracted as described (30 For each reaction, 5 µl of cDNA was amplified in 50 µl directed against rIL-2 and rIL-4 (Genzyme, Boston, MA) were containing 200 µM of each dNTP, 250 ng of each amplification used at concentrations specified in the text. Phorbol 12-primer, 1ϫPCR buffer, 50 mM KCl, 10 mM Tris-HCl, pH 8.4, myristate 13-acetate (PMA) (Sigma, St Louis, MO) was dis-1.5-2 mM MgCl 2 , 0.01% gelatin and 1 U of heat-stable DNA solved in DMSO at 1 mg/ml and used at a final concentration polymerase, either Tth polymerase (Toyobo, Japan) or Hot of 4 ng/ml. CsA, a gift from Sandoz (Basle, Switzerland), was Tub polymerase (Amersham). Samples were overlaid with initially dissolved as a 10% w/v solution in ethanol and diluted mineral oil (Sigma), and amplified by repeated cycles of to a 1 mg/ml stock solution with 2% Tween 80 in RPMI denaturation at 95°C for 60 s, annealing at 58°C for IL-5 and 1640. Cycloheximide (CHX; Calbiochem, La Jolla, CA) was 60°C for β-actin for 30 s and extension at 72°C for 30 s using dissolved at 10 mg/ml in RPMI 1640. RAP, a gift of Wyetha Gene Machine (Innovonics) or Thermal Cycler (Hybaid, Ayerst Research (Princeton, NJ), was stored as a 10 mM Middlesex, UK). Reactions were terminated at PCR cycle ethanol stock solution at -70°C .
numbers where exponential product accumulation was taking Cell culture place, at 30 cycles for IL-5 and 25 cycles for β-actin. The binding sites of PCR primers, synthesized using an Applied PBMC were isolated from the blood of healthy volunteers by Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) density Biosystems DNA synthesizer, were separated by at least one intron to discriminate between cDNA and any co-purified genomic DNA. Hybridization primers were designed to bind a region of cDNA between the amplification primers. β-Actin PCR was performed for each set of experimental samples. IL-5 amplification primers were sense, 5Ј-CGGATCCCACA-GAAATTCCCACAA-3Ј, antisense, 5Ј-TGATATCCACTCGGT-GTTCATTAC-3Ј, with a predicted fragment size of 328 bp, and the hybridization primer was 5Ј-CTTCAGTGCACAGT-TGGTGAT-3Ј. β-actin amplification primers were sense, 5Ј-TCACCAACTGGGACGACATG-3Ј, antisense, 5Ј-GTACAG-GGATAGCACAGCCT-3Ј, with a predicted fragment size of 203 bp, and the hybridization primer was 5Ј-CAGCCATG- TACGTTGCTATC-3Ј (14) .
PBMC were stimulated with 10 U/ml rIL-2, 1 µg/ml PHA or medium alone and cells were harvested at the times indicated. RT-PCR and PCR products were ethanol precipitated, electrophoresed
Southern blotting were performed as described. in 1.3% agarose gels (SeaKem; FMC, Rockland, MA) stained with ethidium bromide and photographed. In some experiments gels were transferred onto Hybond-Nϩ nylon membrane (Amersham) in 0.4 M NaOH under vacuum (Vacugene; illustrated in Fig. 1(A) , induction of IL-5 mRNA by rIL-2 was Pharmacia). Membranes were neutralized in 2ϫSSC and dose dependent, with maximal expression occurring at 10 U/ prehybridized in 7% SDS, 0.25 M Na phosphate, pH 7.2, 1 ml rIL-2. IL-5 mRNA was not detected in unstimulated cells, mM EDTA (pH 8) at 50°C for a minimum of 2 h. Then, 120 ng of as we have observed previously (31). β-Actin mRNA was hybridization primer was end-labelled with T4 polynucleotide readily detected in all samples. Treatment with rIL-2 concenkinase (Pharmacia), added to the prehybridization buffer and trations Ͼ10 U/ml did not significantly further enhance IL-5 hybridized at 50°C overnight. The membranes were washed mRNA expression (data not shown). The specificity of IL-5 at room temperature in 2ϫSSC, 0.1% SDS, followed by a high mRNA induction in response to rIL-2 was confirmed by stringency wash in 1ϫSSC, 0.1% SDS at 50°C for 10-15 min.
neutralization with IL-2-specific antibody. As shown in The results presented in Fig. 2 illustrate a similar temporal ILThe capacity of PBMC from healthy volunteers to respond to rIL-2 was examined. Cells were cultured with rIL-2, and 5 induction profile in response to either stimulus. IL-5 mRNA was detectable by 4 h following activation with either PHA or expression of IL-5 and β-actin was assessed by RT-PCR. As Various concentrations of anti-IL-4 antibodies were incubated with 100 U/ml rIL-4 or 10 U/ml rIL-2 for 2 h at 37°C. The cytokine antibody cocktails, or antibody alone, were then added to activated T lymphocytes and the cells cultured for 16 h. RT-PCR and Southern blotting were performed as described. Lanes 1-5, 100 U/ml rIL-4; lanes 8 and 9, 10 U/ml rIL-2. Anti-IL-4 antibody concentrations: lane 1, 0.6 µg/ml; lane 2, 0.2 µg/ml; lane 3, 0.08 µg/ml; lane 4, 0.04 µg/ml; lane 5, 0 µg/ml; lane 6, 0.6 µg/ml; lane 7, 0.08 µg/ml; lane 8, 0.6 µg/ml; lane 9, 0.08 µg/ml. 1-4) or 1 µg/ml PHA (lanes 5-8) for 16 h. IL-5 and β-actin RT-4-6) or 1 µg/ml PHA (lanes 7-9) for 16 h in the presence or absence PCR were conducted and products analysed by gel electrophoresis. of CHX. IL-5 and β-actin RT-PCR products were detected by gel CsA concentrations were: lanes 1 and 5, 0 ng/ml; lanes 2 and 6, 10 electrophoresis. CHX concentrations were: lanes 1, 4 and 7, 0 µg/ ng/ml; lanes 3 and 7, 100 ng/ml; lanes 4 and 8, 1000 ng/ml. ml; lanes 2, 5 and 8, 10 µg/ml; lanes 3, 6 and 9, 40 µg/ml. rIL-2, and was declining at 48 h. PHA induced peak IL-5 4 to increasing concentrations of antibody blocked IL-5 mRNA expression (Fig. 3B) , with expression completely abolished expression at 6 h, ahead of the 12 h maximum observed in IL-2-stimulated cells.
at the highest antibody concentrations (lanes 1 and 2). Figure  3 
(B) reveals a doublet in the IL-5 samples. The slower Induction of IL-5 mRNA expression by rIL-4
migrating bands represent specific single-stranded IL-5 PCR products (32). Antibody alone did not affect β-actin expression Cultures of activated T lymphocytes were derived by expanding PHA-stimulated PBMC for 7 days, with addition of (lanes 6 and 7). IL-2-induced IL-5 mRNA expression was not abolished by IL-4-specific antibodies (lanes 8 and 9). 5 U/ml rIL-2 on day 3. These cells are referred to as activated T lymphocytes throughout this report. Surface phenotype Effect of CHX, CsA and RAP on IL-5 mRNA expression analysis revealed that at 7 days, the cells were 99% CD3 ϩ and 97% CD25 ϩ . Upon re-stimulation with PHA or rIL-2, The requirement for de novo protein synthesis for initiation of IL-5 transcription was examined by addition of the protein inducible IL-5 mRNA expression was very readily detected in these cells (data not shown). In order to determine whether synthesis inhibitor CHX to activated T lymphocytes. As illustrated in Fig. 4 , the presence of CHX prevented the induction IL-4 also conferred a stimulatory effect on IL-5 gene transcription, activated T lymphocytes were cultured with a range of rILof IL-5 mRNA expression in response to both IL-2 (lanes 4-6) and PHA (lanes [7] [8] [9] . Treatment of the cultures with CHX 4 concentrations and IL-5 mRNA expression was assessed. 3) . This finding suggests that the IL-5 gene is transcriptionally mRNA, with maximum expression detected at the highest concentration of 300 U/ml. IL-5 mRNA expression was not silent in resting cells, and is not constitutively expressed and regulated by rapid mRNA degradation by labile proteins. detected in fresh PBMC exposed to rIL-4 (data not shown). The specificity of the effect of rIL-4 was demonstrated by
The effect of various concentrations of CsA on the induction of IL-5 mRNA expression by IL-2 in activated T lymphocytes inhibition with an IL-4 neutralizing antibody. Exposure of rIL- (Fig. 3) . rIL-2 and rIL-4 also induce IL-5 mRNA expression in the murine T h 2 clone D10 alone for 16 h (Fig. 6 ). rIL-2-stimulated IL-5 expression was unaffected by treatment with up to 1000 nM RAP (lanes 7-(33). The induction of IL-5 by IL-4 is consistent with experiments in mice lacking functional IL-4 genes, in which IL-4 is 12). Proliferation induced by rIL-2 was inhibited by up to 60% by 100 nM RAP (data not shown). By contrast, PHA-induced essential for the differentiation of cells which produce IL-5 (34). The convergent induction of IL-5 expression by both IL-IL-5 mRNA expression was inhibited by RAP in a dosedependent fashion (lanes 13-18) . A similar divergent 2 and IL-4 may be due to the presence of the common γ chain in the high-affinity IL-2R and IL-4R. The inability to response to RAP was observed in PBMC, where PHA stimulated IL-5 expression was~1000-fold more sensitive to inhibidetect IL-5 mRNA expression in fresh PBMC exposed to rIL-4 may be due to a lack of sensitivity in detecting IL-5 mRNA tion by RAP than IL-5 expression induced by rIL-2 (data not shown).
expression by the small proportion of IL-4-responsive T cells in PBMC (35). To further investigate the effect of RAP on IL-5 expression, activated T lymphocytes were stimulated with either rIL-2 or Induction of IL-5 expression by IL-2 or by PHA was differentially susceptible to immunosuppressive agents. Induction of PHA in the presence or absence of 100 nM RAP, and cells were harvested at 4, 8, 12 and 24 h after activation. IL-2-IL-5 by PHA was inhibited by CsA (Fig. 5 ), in agreement with the findings of others (15, 16) . CsA binds to cyclophilin and induced IL-5 mRNA expression was resistant to RAP at 4, 12 and 24 h (Fig. 7, lanes 3, 11 and 15 ). In this figure RAP this complex inhibits the calcium-dependent phosphatase, calcineurin (36) , thereby preventing the dephosphorylation appeared to down-regulate IL-2-induced IL-5 expression at 8 h (lane 6 compared with lane 7); however, this inhibition and nuclear translocation of the cytoplasmic component of nuclear factor of activated T cells (NF-AT) (37) . Cyclophilin A was not reproduced in two other time-course experiments. In cells stimulated with PHA, RAP completely abolished IL-5 is the best described cyclophilin but cyclophilin B is also present in T cells and both confer susceptibility to CsA (38) . mRNA at 24 h (lane 17) and had a less marked inhibitory effect at earlier time points (lanes 5, 9 and 13).
It is not clear whether one of these cyclophilins is more important in the effects of CsA on T cells. There is increasing evidence for the involvement of NF-AT in the regulation Discussion of most cytokine genes expressed by T cells (39) . The susceptibility of IL-5 expression to CsA suggests that IL-5 In this communication we report that IL-5 mRNA can be induced by IL-2 in the PBMC of normal individuals. Thus ILis also regulated by a member of the NF-AT transcription factor family. 5 gene expression may be induced by either IL-2-or TCRassociated signalling pathways. The induction of IL-5 gene By contrast, IL-2-mediated IL-5 expression was resistant to CsA (Fig. 5) . This is consistent with the observation that activation by IL-2 raises the possibility that production of IL-2 is required for IL-5 expression when T cells are activated addition of exogenous IL-2 to CsA-treated mitogen activated T cell cultures overcomes the antiproliferative effects of CsA through the TCR. If this were the case, a time lag between (40) is most likely to account for the lack of sensitivity to CsA of both IL-2-induced proliferation (Fig. 4) . Therefore in addition to the potential involvement of the pre-existing STATs, other, newly synthesized, regulatory and IL-5 expression. Similar resistance to CsA in IL-2-stimulated IFN-γ and GM-CSF synthesis has been reported in proteins are also required for IL-2-induced IL-5 transcription. The effect of RAP on TCR-stimulated lymphokine expression murine T cell clones (41, 42) . Thus IL-5 transcription can be induced by two different signalling mechanisms, one involving is controversial. T cell lymphokine gene transcription, 3-6 h after activation, was reported to be unaffected by RAP (21,23); calcium-dependent signals arising from TCR stimulation and an IL-2-activated pathway that is independent of calciumhowever, in another report, RAP diminished IL-2 and GM-CSF mRNA (24). A 16 h exposure of PHA-stimulated T lymphocytes mediated events.
RAP is an immunosuppressive agent that inhibits T cell to RAP caused dose-dependent suppression of IL-5 mRNA expression (Fig. 6) . However, at 4 and 8 h, PHA-induced ILproliferation in response to IL-2. It therefore seemed reasonable to expect that RAP would inhibit IL-5 mRNA induction 5 mRNA was relatively resistant to RAP (Fig. 7) . Thus the discrepancy between the previously published results may by IL-2, but this was not the case. RAP did not inhibit IL-5 expression at concentrations that caused up to 60% reduction be due to sampling times. The late onset of inhibition of IL-5 expression by RAP is consistent with its inhibitory effect on a in proliferation (Figs 6 and 7, and data not shown). The divergent effects of RAP on IL-2-induced proliferation and target in the G 1 phase, as has been proposed for the antiproliferative effect of RAP (22) . IL-5 expression may be explained by the recent definition of separate pathways that mediate the mitotic response and In summary, IL-5 gene transcription in human T cells can be induced by TCR-or cytokine-mediated activation. Jak/STAT signalling. The antiproliferative effects of RAP correlate with inhibition of IL-2-induced bcl-2 expression (43) .
Stimulation of either pathway induces similar IL-5 mRNA expression kinetics and requires de novo synthesis of reguSignalling through the IL-2R recruits Jak1 and Jak3 which phosphorylate and activate at least three signal transducers latory proteins. Despite these similarities, the different response to treatment with immunosuppressive agents indiand activators of transcription (STAT), Stat1, Stat3 and Stat5, allowing subsequent nuclear translocation and induction of cates that mitogen and IL-2 signalling involve separate pathways that independently regulate IL-5 expression. Induction certain IL-2-responsive genes (44) (45) (46) . Activation of Stat5 by IL-2 involves a region of the IL-2R β chain that is not necessary of IL-5 mRNA by mitogen activation is susceptible to inhibition by CsA and RAP, whereas IL-2-mediated IL-5 induction is for IL-2-induced cell proliferation and nuclear translocation of Stat5 was unaffected by RAP (47, 48) . By contrast, TCR signal resistant to these agents. These findings have implications for the use of CsA and RAP in the treatment of diseases transduction by PHA or anti-CD3 antibody does not involve activation of Jak/STAT pathways (49, 50) and RAP did inhibit associated with IL-5, such as asthma. The findings suggest that if CsA or RAP were used alone, IL-5 could still be induced IL-5 expression induced by PHA. These findings are consistent with the possibility that Jak/STAT pathways are involved if any IL-2 were present. However, IL-2-mediated induction of IL-5 is susceptible to glucocorticoids (14) and the use of in the induction of IL-5 by IL-2.
A consensus TTC(N)3GAA motif for selective Stat1, 3 and CsA or RAP in combination with glucocorticoids would provide inhibition of the TCR and IL-2 receptor pathways. 5 binding has been defined (46) . Analysis of 1.5 kb of DNA sequence flanking the 5Ј region of the IL-5 gene revealed a single match~1 kb upstream of the IL-5 gene. Thus it
